Exchange: NASDAQ·Updated 05:15 PM EDT
GNTA logo

GNTA Genenta Science SpA - ADR

$1.03
$0.0093
(0.94%)
Today
Closed $1.00
$0.03
(3.00%)
After Hours
Mkt Cap$23.43M
Vol58,851.00

About GNTA

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
48

Neutral Sentiment

How do you feel about GNTA?

Advertisement|Remove ads.